Kainate Receptor-Selective Epimeric Analogs of Dysiherbaine

Disclosed are compounds, pharmaceutical compositions, methods of treatment, and methods for selectively antagonizing a GluR5 receptor, a GluR6 receptor, or both receptors. The pharmaceutical compositions include and the methods utilize compounds that are analogs and stereoisomers of dysiherbaine and neodysiherbaine which have specificity for kainate receptors.

Attached files:


Patents:
US 20,090,118,358

Inventor(s): SWANSON GEOFFREY T [US]; LASH LEANNE [US]

Type of Offer: Licensing



« More Pharmaceutical Patents

---